Gastric Disease
Gastric Disease(胃病)
Gastric Disease 相关产品(92)
- GC18397R-(-)-α-Methylhistamine (hydrochloride)CAS: 75614-89-0纯度: >98.00%
A histamine H 3 receptor agonist
- GC1878313,14-dihydro-15-keto Prostaglandin E1CAS: 5094-14-4纯度: >98.00%
An inactive metabolite of PGE 1
- GC33877Tetrahydrocoptisine ((RS)-Stylopine)CAS: 4312-32-7
An alkaloid with anti-inflammatory and antioxidant activities
- GC40094all-trans Retinoic Acid-d5纯度: >99.00%
An internal standard for the quantification of all-trans retinoic acid
- GC40218(-)-Epigallocatechin Gallate-d3/d4纯度: >99.00%
An internal standard for the quantification of (–)-epigallocatechin gallate
- GC41406AMP-DeoxynojirimycinCAS: 216758-20-2纯度: >95.00%
Inhibitor of glucosylceramide synthase and non-lysosomal glucosylceramidase
- GC42713ACTH (1-10) (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)纯度: >95.00%
A peptide fragment of ACTH
- GC43252Cholesterol β-D-GlucosideCAS: 7073-61-2纯度: >95.00%
A glycosylated derivative of cholesterol
- GC43412Desacetyl BisacodylCAS: 603-41-8纯度: >97.00%
An active metabolite of the laxatives bisacodyl and sodium picosulfate
- GC44993Taurocholic Acid (sodium salt)CAS: 145-42-6纯度: >95.00% / >97.00% / >98.00%
Taurocholic Acid (sodium salt)是一种牛磺酸结合形式的主要胆汁酸，具有显著的生物活性作用。
- GC45539Pantoprazole-d6CAS: 922727-65-9纯度: >99.00%
An internal standard for the quantification of pantoprazole
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC18245 | Stachyose | 470-55-3 | >80.00% | |
Stachyose是一种寡糖，也是一种益生元。 | ||||
| GC18298 | Virstatin | 88909-96-0 | - | |
An inhibitor of the ToxT transcriptional regulator | ||||
| GC18313 | BAR501 Impurity | 1632118-70-7 | - | |
A GP-BAR1 agonist | ||||
| GC18397 | R-(-)-α-Methylhistamine (hydrochloride) | 75614-89-0 | >98.00% | |
A histamine H 3 receptor agonist | ||||
| GC18426 | 8-Nitroguanine | 168701-80-2 | - | |
A mutagenic nitrative guanine derivative | ||||
| GC18487 | BC-1215 | 1507370-20-8 | >99.50% | |
An inhibitor of FBXO3 | ||||
| GC18783 | 13,14-dihydro-15-keto Prostaglandin E1 | 5094-14-4 | >98.00% | |
An inactive metabolite of PGE 1 | ||||
| GC30578 | Nigakinone | 18110-86-6 | >98.00% | |
Nigakinone是苦木中含量最丰富的生物碱之一，具有重要的药理活性。 | ||||
| GC33877 | Tetrahydrocoptisine ((RS)-Stylopine) | 4312-32-7 | - | |
An alkaloid with anti-inflammatory and antioxidant activities | ||||
| GC40094 | all-trans Retinoic Acid-d5 | - | >99.00% | |
An internal standard for the quantification of all-trans retinoic acid | ||||
| GC40218 | (-)-Epigallocatechin Gallate-d3/d4 | - | >99.00% | |
An internal standard for the quantification of (–)-epigallocatechin gallate | ||||
| GC40298 | N-acetyl-5-Aminosalicylic Acid | 51-59-2 | >98.00% | |
A metabolite of 5-ASA and sulfasalazine | ||||
| GC40555 | Tiopronin | 1953-02-2 | >98.00% | |
Tiopronin is an antioxidant that has diverse biological activities. | ||||
| GC40627 | tetranor-Misoprostol | - | >95.00% | |
A metabolite of misoprostol | ||||
| GC41406 | AMP-Deoxynojirimycin | 216758-20-2 | >95.00% | |
Inhibitor of glucosylceramide synthase and non-lysosomal glucosylceramidase | ||||
| GC42713 | ACTH (1-10) (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) | - | >95.00% | |
A peptide fragment of ACTH | ||||
| GC43113 | Caerulein (acetate) | 2760881-68-1 | >95.00% | |
An oligopeptide | ||||
| GC43252 | Cholesterol β-D-Glucoside | 7073-61-2 | >95.00% | |
A glycosylated derivative of cholesterol | ||||
| GC43412 | Desacetyl Bisacodyl | 603-41-8 | >97.00% | |
An active metabolite of the laxatives bisacodyl and sodium picosulfate | ||||
| GC44510 | ONO-AE3-208 (sodium salt) | 2309931-05-1 | >95.00% | |
An EP 4 receptor antagonist | ||||
| GC44555 | Pantoprazole sulfone | 127780-16-9 | >98.00% | |
A pantoprazole metabolite | ||||
| GC44993 | Taurocholic Acid (sodium salt) | 145-42-6 | >95.00% / >97.00% / >98.00% | |
Taurocholic Acid (sodium salt)是一种牛磺酸结合形式的主要胆汁酸，具有显著的生物活性作用。 | ||||
| GC45285 | 1,2,3-Trihexanoyl-rac-glycerol | 621-70-5 | >95.00% | |
A triacylglycerol | ||||
| GC45539 | Pantoprazole-d6 | 922727-65-9 | >99.00% | |
An internal standard for the quantification of pantoprazole | ||||